• Morbid obesity increases CVD risk due to its effect on blood lipid levels.

• Weight loss improves blood lipid levels by lowering triglycerides and LDL (“bad”) cholesterol and increasing HDL (“good”) cholesterol.

• Weight loss of 5% to 10% can reduce total blood cholesterol.

• The effects of morbid obesity on cardiovascular health can begin in childhood, which increases the risk of developing CVD as an adult.

• Morbid obesity increases the risk of illness and death associated with coronary heart disease.

• Morbid obesity is a major risk factor for heart attack, and is now recognized as such by the American Heart Association.

• Morbid Obesity has been established as a risk factor for CTS.

• The odds of an obese patient having CTS were found in one study to be almost four times greater than that of a non-obese patient.

• Morbid Obesity was found in one study to be a stronger risk factor for CTS than workplace activity that requires repetitive and forceful hand use.

• Seventy percent of persons in a recent CTS study were overweight or obese.

Chronic Venous Insufficiency (CVI) from Morbid Obesity

Patients with CVI, an inadequate blood flow through the veins, tend to be older, male, and have obesity.

Daytime Sleepiness from Morbid Obesity

• People with morbid obesity frequently complain of daytime sleepiness and fatigue, two probable causes of mass transportation accidents.

• Severe obesity has been associated with increased daytime sleepiness even in the absence of sleep apnea or other breathing disorders.

Deep Vein Thrombosis (DVT) from Morbid Obesity

• Morbid Obesity increases the risk of DVT, a condition that disrupts the normal process of blood clotting.

• Patients with obesity have an increased risk of DVT after surgery.

Diabetes (Type 2) from Morbid Obesity

• As many as 90% of individuals with type 2 diabetes are reported to be overweight or obese.

• Morbid Obesity has been found to be the largest environmental influence on the prevalence of diabetes in a population.

• Morbid Obesity complicates the management of type 2 diabetes by increasing insulin resistance and glucose intolerance, which makes drug treatment for type 2 diabetes less effective.

• A weight loss of as little as 5% can reduce high blood sugar.

End Stage Renal Disease (ESRD) from Morbid Obesity

Morbid Obesity may be a direct or indirect factor in the initiation or progression of renal disease, as suggested in preliminary data.

Gallbladder Disease from Morbid Obesity

• Morbid Obesity is an established predictor of gallbladder disease.

• Morbid Obesity and rapid weight loss in obese persons are known risk factors for gallstones.

• Gallstones are common among overweight and obese persons. Gallstones appear in persons with obesity at a rate of 30% versus 10% in non-obese.

Gout from Morbid Obesity

• Morbid Obesity contributes to the cause of gout -- the deposit of uric acid crystals in joints and tissue.

• Morbid Obesity is associated with increased production of uric acid and decreased elimination from the body.

Heat Disorders from Morbid Obesity

• Morbid Obesity has been found to be a risk factor for heat injury and heat disorders.
• Poor heat tolerance is often associated with obesity.

Hypertension from Morbid Obesity

• Over 75% of hypertension cases are reported to be directly attributed to obesity.
• Weight or BMI in association with age is the strongest indicator of blood pressure in humans.
• The association between obesity and high blood pressure has been observed in virtually all societies, ages, ethnic groups, and in both genders.
• The risk of developing hypertension is five to six times greater in obese adult Americans, age 20 to 45, compared to non-obese individuals of the same age.

Impaired Immune Response from Morbid Obesity

• Obesity has been found to decrease the body’s resistance to harmful organisms.
• A decrease in the activity of scavenger cells, that destroy bacteria and foreign organisms in the body, has been observed in patients with obesity.

Impaired Respiratory Function from Morbid Obesity

• Obesity is associated with impairment in respiratory function.
• Obesity has been found to increase respiratory resistance, which in turn may cause breathlessness.
• Decreases in lung volume with increasing obesity have been reported.

Infections Following Wounds from Morbid Obesity

• Obesity is associated with the increased incidence of wound infection.
• Burn patients with obesity are reported to develop pneumonia and wound infection with twice the frequency of non-obese.

Infertility from Morbid Obesity

• Obesity increases the risk for several reproductive disorders, negatively affecting normal menstrual function and fertility.
• Weight loss of about 10% of initial weight is effective in improving menstrual regularity, ovulation, hormonal profiles and pregnancy rates.

Liver Disease from Morbid Obesity

• Excess weight is reported to be an independent risk factor for the development of alcohol related liver diseases including cirrhosis and acute hepatitis.
• Obesity is the most common factor of nonalcoholic steatohepatitis, a major cause of progressive liver disease.

Low Back Pain from Morbid Obesity

• Obesity may play a part in aggravating a simple low back problem, and contribute to a long-lasting or recurring condition.
• Women who are overweight or have a large waist size are reported to be particularly at risk for low back pain.

Obstetric and Gynecologic Complications from Morbid Obesity

• Women with severe obesity have a menstrual disturbance rate three times higher than that of women with normal weight.
• High pre-pregnancy weight is associated with an increased risk during pregnancy of hypertension, gestational diabetes, urinary infection, Cesarean section and toxemia.
• Morbid Obesity is reportedly associated with the increased incidence of overdue births, induced labor and longer labors.
• Women with maternal obesity have more Cesarean deliveries and higher incidence of blood loss during delivery as well as infection and wound complication after surgery.
• Complications after childbirth associated with obesity include an increased risk of endometrial infection and inflammation, urinary tract infection and urinary incontinence.

Pain from Morbid Obesity

• Bodily pain is a prevalent problem among persons with obesity.
• Greater disability, due to bodily pain, has been reported by persons with obesity compared to persons with other chronic medical conditions.
• Morbid Obesity is known to be associated with musculoskeletal or joint-related pain.
• Foot pain located at the heel, known as Sever’s disease, is commonly associated with obesity.

Pancreatitis from Morbid Obesity

• Obesity is a predictive factor of outcome in acute pancreatitis. Obese patients with acute pancreatitis are reported to develop significantly more complications, including respiratory failure, than non-obese.
• Patients with severe pancreatitis have been found to have a higher body-fat percentage and larger waist size than patients with mild pancreatitis.

Sleep Apnea from Morbid Obesity

• Obesity, particularly upper body obesity, is the most significant risk factor for obstructive sleep apnea.
• There is a 12 to 30-fold higher incidence of obstructive sleep apnea among morbidly obese patients compared to the general population.
• Among patients with obstructive sleep apnea, at least 60% to 70% are obese.

Stroke from Morbid Obesity

• Elevated BMI is reported to increase the risk of ischemic stroke independent of other risk factors including age and systolic blood pressure.
• Abdominal obesity appears to predict the risk of stroke in men.
• Obesity and weight gain are risk factors for ischemic and total stroke in women.

Urinary Stress Incontinence from Morbid Obesity

• Morbid Obesity is a well-documented risk factor for urinary stress incontinence, involuntary urine loss, as well as urge incontinence and urgency among women.
• Morbid Obesity is reported to be a strong risk factor for several urinary symptoms after pregnancy and delivery, continuing as much as 6 to 18 months after childbirth.